Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Microbix Biosystems Inc T.MBX

Alternate Symbol(s):  MBXBF

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.


TSX:MBX - Post by User

Comment by Mbxwatcheron May 17, 2021 12:07pm
130 Views
Post# 33214285

RE:Question: will free cash flow increase going forward?

RE:Question: will free cash flow increase going forward?
I listened to the entire Webinar, and the stock price, frustratingly, makes no sense.
At the very moment he annouced such positive momentum across the next few quarters (the visibility he is comfortable proclaiming), a large block of shares brought the  price down to .58.

He did comment on institutions buying and selling shares to keep the warrant, and he did say that they would ultimately regret that with MBX, but that it was common practice.

Overall everything he said, was said with enthusiasm and confidence, and it is hard to find a reason both for the current shareprice, and what will hold it back in the near future.  

Congratulations to Cameron and his team for what appears to be the successful transition of al fledgling business into what appears to be significant growth, and profitablility.

A comfortable hold for sure, while certainly frustrated with the current performance of the share price.
<< Previous
Bullboard Posts
Next >>